9-Benzyl-1-oxa-9-azaspiro[5.5]undecan-4-aminedihydrochloride
95%
- Product Code: 75839
CAS:
1332531-13-1
| Molecular Weight: | 333.3 g./mol | Molecular Formula: | C₁₆H₂₆Cl₂N₂O |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD19103509 | |
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | 2-8℃ |
Product Description:
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. Its unique spirocyclic structure makes it valuable in the development of drugs targeting the central nervous system, particularly for conditions like anxiety, depression, and neurodegenerative disorders. Researchers leverage its chemical framework to design compounds with enhanced binding affinity and selectivity for specific receptors or enzymes. Additionally, it has shown potential in the creation of novel analgesics and anti-inflammatory agents, contributing to advancements in pain management therapies. Its application extends to the optimization of drug candidates for improved pharmacokinetic properties, such as bioavailability and metabolic stability.
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.500 | 10-20 days | $2,658.21 |
+
-
|
9-Benzyl-1-oxa-9-azaspiro[5.5]undecan-4-aminedihydrochloride
This compound is primarily utilized in the field of medicinal chemistry as a key intermediate in the synthesis of various pharmacologically active molecules. Its unique spirocyclic structure makes it valuable in the development of drugs targeting the central nervous system, particularly for conditions like anxiety, depression, and neurodegenerative disorders. Researchers leverage its chemical framework to design compounds with enhanced binding affinity and selectivity for specific receptors or enzymes. Additionally, it has shown potential in the creation of novel analgesics and anti-inflammatory agents, contributing to advancements in pain management therapies. Its application extends to the optimization of drug candidates for improved pharmacokinetic properties, such as bioavailability and metabolic stability.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
$0.00
$0.00
Total :